LAS VEGAS — At the Eyecelerator@ASCRS meeting, Jeffrey Nau, PhD, MMS, president and CEO of Oyster Point Pharma, discusses OC-01 nasal spray for dry eye disease and two additional pipeline programs.
Uncategorized
VIDEO: Oyster Point Pharma presents data on OC-01, other pipeline projects